Search clinical trials for: Yellow fever vaccine

Total 11209 results

Fondazione IRCCS Ca' Granda, Ospedale Maggiore...

Unknown

Normothermia in Patients With Acute Cerebral Damage

Traumatic Brain Injury | Subarachnoid Hemorrhage

Italy
National Institute of Allergy and Infectious Diseases...

Completed

Determining an Effective Site (Groin Versus Arm) for Giving HIV Vaccines

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Unknown

Resistance to HIV Infection

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Analysis of Immune Responses to HIV Vaccines

HIV Infections | Acquired Immunodeficiency Syndrome

United States
National Institute of Allergy and Infectious Diseases...

Completed

Therapeutic Vaccination Followed by Treatment Interruption in HIV Infected Patients

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

HIV Vaccine Designed for HIV Infected Adults Taking Anti-HIV Drugs

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Evaluation of the Safety of and Immune Response to an HIV Vaccine in Healthy Adults

HIV Infections

Australia
José Mordoh, M.D., Ph.D.

Completed

Vaccination of Melanoma Patients With Dendritic Cells Loaded With Allogeneic Apoptotic-Necrotic Melanoma Cells

Melanoma

Argentina
European Malaria Vaccine Initiative

Unknown

GMZ2-Aluminum Hydroxide Phase I, Tübingen

Malaria

Germany
Norwegian Institute of Public Health

Completed

Immunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio Vaccine

Pertussis | Tetanus | Diphtheria | Polio

Norway
GlaxoSmithKline

Completed

Safety and Efficacy of SmithKline Beecham (GlaxoSmithKline [GSK]) Biologicals' Candidate Adjuvanted Vaccines (287615)

Hepatitis B Disease

Belgium
Shaare Zedek Medical Center

Unknown

Urinary Catheter Exchange on Admission of Septic Elderly With Permanent Catheter Before Initiation of Antibiotics

Fever | Blood Pressure | Heart Rate | Erythrocyte Sedimentation Rate | C-Reactive Protein
MedImmune LLC

Completed

Study To Evaluate the Safety of Bivalent Vaccine

Healthy

United States
Diabetica Solutions Inc.
National Institutes of Health (NIH)

Unknown

Novel Home Care Device for High-Risk Diabetic Patients (TempTouchRM)

Diabetes | Elevated Temperature | Neuropathic Limb | Shear Pressure | Increased Temperatures

United States
HaEmek Medical Center, Israel

Completed

The Effectiveness of Influenza Vaccine Among Health Care Workers in a Hospital Setting.

Influenza Vaccines

Israel
University of Oxford

Completed

Safety and Immunogenicity of MVA85A in Volunteers Latently Infected With TB.

Tuberculosis

United Kingdom
University of Oxford

Completed

A Study of the Immunogenicity of BCG, Delivered Intradermally in Healthy Volunteers

TB

United Kingdom
MedImmune LLC

Completed

Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy Adults

Healthy | Influenza

United States
Assaf-Harofeh Medical Center

Unknown

Orthostatic Hypotension in Children With Acute Febrile Illness

Fever | Orthostatic Hypotension

Israel
The University of New South Wales
St Vincent's Hospital, Sydney; Australian Government Department of Health and... and other collaborators

Unknown

Trial of Modafinil for Methamphetamine Dependence

Amphetamine Dependence

Australia
The University of New South Wales
St Vincent's Hospital, Sydney; Australian Government Department of Health and... and other collaborators

Unknown

Randomised Placebo-Controlled Trial of Modafinil for Cocaine Dependence

Cocaine Dependence

Australia
Tel-Aviv Sourasky Medical Center

Terminated

The Effect of Rituximab on the Humoral Response to Influenza Vaccine

Rheumatoid Arthritis
Medical University of Vienna

Completed

Vasoactive Intestinal Peptide in COPD (VIPCOPD)

Pulmonary Hypertension | COPD
St. Joseph's Health Care London

Completed

Efficacy Study of Combined Hepatitis A and Hepatitis B Vaccine to Protect Against Hepatitis B in Hemodialysis Patients

Hepatitis B

Canada
Seoul National University Hospital
HK inno.N Corporation

Completed

Safety and Immunogenicity of CJ-50300

Smallpox

Korea, Republic of
Centers for Disease Control and Prevention
Southcentral Foundation; Alaska Native Tribal Health Consortium

Completed

Immunogenicity and Reactogenicity of Pneumococcal Polysaccharide and Conjugate Vaccines in Native Elders

Pneumococcal Infections

United States
Centers for Disease Control and Prevention
Johns Hopkins University; University of Pittsburgh; Maryland Department of Health... and other collaborators

Completed

Effect of Meningococcal Conjugate Vaccine on Meningococcal Carriage

Meningitis
French National Agency for Research on AIDS and...

Completed

Safety of Intradermal Versus Intramuscular Administration of HIV Lipopeptides in HIV Uninfected Adult Volunteers

HIV Infections | HIV Seronegativity

France
Novartis
Novartis Vaccines

Completed

Safety and Immunogenicity of Preservative Free Inactivated Split Influenza Vaccine, Using the Strain Composition 2006/2007 in Non-Elderly Adult and Elderly Subjects

Influenza

Germany
Novartis
Novartis Vaccines

Completed

Safety and Immunogenicity of Two Doses, Administered Three Weeks Apart, of Two(Surface Antigen Adjuvanted With MF59C.1) Influenza Vaccines in Non-Elderly Adult and Elderly Subjects

Pandemic Influenza Disease

Italy
Novartis
Novartis Vaccines

Completed

Evaluation of Long-Term Immunogenicity in Subjects Boosted With a TBE Vaccine for Adults

Encephalitis, Tick-Borne

Germany
Novartis
Novartis Vaccines

Completed

Immunogenicity, Safety and Tolerability, of Chiron Meningococcal C Conjugate Vaccine Administered to Healthy Premature and Non Premature Children of 3 Months of Age

Prevention of Meningococcal Infection

Italy
European Malaria Vaccine Initiative
University of Oxford; Wellcome Trust

Completed

Safety and Immunogenicity Study of the Malaria Vaccines FP9 PP and MVA PP

Malaria | Malaria, Falciparum

United Kingdom
Kirby Institute
The University of New South Wales; Virax Pty. Ltd,

Completed

ITV Extension Study

HIV

Australia
Canadian Critical Care Trials Group
The Physicians' Services Incorporated Foundation

Completed

Pilot Study of the Utility of Empiric Antibiotic Therapy for Suspected ICU-Acquired Infection

Pneumonia | Systemic Inflammatory Response Syndrome | Critical Illness | Nosocomial Infection | Pyrexia

Canada
Ruhr University of Bochum

Completed

Effects of Benfotiamine and AGE on Endothelial Function in People With Diabetes (AGE-Benfo)

Type 2 Diabetes Mellitus | Endothelial Dysfunction

Germany
University Health Network, Toronto

Unknown

Pneumonia Vaccine in Liver Transplant Recipients: a Booster Strategy Using a Conjugate Vaccine

Transplant

Canada
IDRI
Bill and Melinda Gates Foundation

Completed

Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Mucosal Leishmaniasis

Leishmaniasis, Mucocutaneous

Peru
IDRI
Bill and Melinda Gates Foundation

Completed

Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Cutaneous Leishmaniasis

Leishmaniasis, Cutaneous

Brazil
Henogen

Completed

Evaluation of Safety, Immune-Response and Efficacy of GSK Biologicals' EBV (Epstein Barr Virus) Vaccine (268664).

Epstein Barr Virus (EBV) Infection

Belgium
Royal Brompton & Harefield NHS Foundation Trust

Completed

Oral Allergy Syndrome (OAS): a Pilot Study to Evaluate a Clinical Questionnaire as a Diagnostic Tool

Rhinitis | Food Allergy

United Kingdom
PowderMed

Completed

Safety Study of HSV2 DNA Vaccine to Treat Patients With Recurrent Genital Herpes Caused by HSV-2

HSV-2

United States
PowderMed

Completed

Safety Study of an Influenza Vaccine Against a Potential Pandemic Strain of Flu

Influenza (Pandemic)

United Kingdom
PowderMed

Completed

Study of the Ability of a Flu Vaccine to Prevent Flu Infection

Influenza

United Kingdom
PowderMed

Completed

A Safety and Immunology Study of a DNA Trivalent Influenza Vaccine

Influenza

United States
University of Oxford

Completed

A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Previously Received BCG

Tuberculosis

United Kingdom
University of Oxford

Completed

A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Received BCG Immunisation 1 Month Previously

Tuberculosis

United Kingdom
ID Biomedical Corporation, Quebec

Completed

Study Comparing Immune Response to, and Safety of, Fluviral and Fluzone Influenza Vaccines in Persons 50 y.o. and Over

Influenza

United States
University of Oxford

Completed

A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers.

Tuberculosis

United Kingdom
University of Oxford

Completed

A Phase I Study of the Safety and Immunogenicity of MVA85A in Healthy Gambian Volunteers

Tuberculosis

Gambia

3

Subscribe